Skip to main content
. 2018 Dec 23;56(6):340–345. doi: 10.5114/reum.2018.80710

Table III.

General summary of the number of people who generate indirect costs taking into account age, according to the treatment regimen

  Infliximab Etanercept Adalimumab
Disability pension 6 3 6
Pension 6 5 6
Survivor's pension 1 2 2
Social pension 1 0 0
Age range 27–71 20–60 25–77
Age average 47 51 54